FDA still has not published congressionally required cannabinoid lists and container guidance as major federal hemp restrictions approach. The delay leaves manufacturers and retailers facing uncertainty around reformulation, packaging, potency, inventory, product classification, and compliance before the November 12 transition.

Canada still supplies most of Australia's imported medical cannabis, but Thailand rapidly gained market share in 2025 while Australian domestic production reached a new high. The shift shows an increasingly competitive supply chain where pricing, quality standards, contracts, inventory, and reliable international market access matter more.

Missouri received nearly 900 applications for 77 licenses in its final cannabis microbusiness round, with the lottery scheduled for September 9. New ownership and vetting rules mean selection alone will not guarantee a license, increasing pressure around control, financing, compliance, and post selection readiness.

A study of 4,516 people found that 65 percent reported drinking less alcohol while consuming cannabis beverages, with participants also reporting changes in sleep, mood, anxiety, and pain. The findings strengthen the cannabis beverage opportunity while increasing pressure around dosage, consumer education, product claims, regulation, and responsible marketing.

New Mexico cannabis sales remain steady as Texas border communities help support demand, but heavy retail density and lower average transactions are increasing pressure on margins. The market shows why mature cannabis operators need to focus on location economics, pricing, competition, and long term profitability rather than statewide sales alone.

Palomar is asking a federal court to rule that its general liability and product liability policies do not cover Cresco Labs in two major consumer class actions. The dispute highlights growing cannabis insurance pressure around marketing claims, product warnings, economic losses, exclusions, defense costs, and the difference between having a policy and having coverage for a specific lawsuit.

Distressed cannabis cultivation facilities are attracting interest from data center developers because many already contain valuable electrical, cooling, climate, and security infrastructure. The opportunity is real but selective, with power capacity, fiber access, zoning, property size, and location determining whether an alternative use can actually work.

South Dakota medical cannabis home cultivation has increased more than 1,000 percent in four years, rising from 61 authorized patients to 715. The surge highlights growing pressure around affordability, patient access, dispensary strategy, cultivation oversight, and the balance between personal cultivation and the regulated commercial market.

Rhode Island cannabis retail licensing is moving again after a federal judge lifted an injunction that had frozen the state's application and selection process. Applicants now face a revised system with new deadlines, updated ownership rules, site control requirements, and renewed pressure around capital and market entry.

A Yale Budget Lab analysis estimates federal cannabis legalization could produce $57.9 billion in federal excise tax revenue over ten years, rising to $111.3 billion if every remaining state also legalizes. The bigger operator question is how legalization would reshape taxation, 280E, banking, interstate commerce, illicit market competition, and the economics of the regulated industry.